Beijing Yingkerei Pharmaceutical Technology

Beijing Yingkerei Pharmaceutical Technology is a prominent Chinese biopharmaceutical company specializing in the modernization of Traditional Chinese Medicine (TCM) and the development of high-barrier drug delivery systems. Founded in 1999 and headquartered in Beijing, the company operates a comprehensive R&D ecosystem with core expertise in atomization inhalation preparations, microsphere formulations, and innovative TCM compounds. Yingkerei functions as both a proprietary drug developer and a Contract Research Organization (CRO), providing end-to-end services from drug discovery to clinical research. Its pipeline features numerous candidates targeting respiratory, cardiovascular, and infectious diseases, including the YKRH00020 inhalation solution for COPD and several late-stage TCM-based therapies. With a network of subsidiaries in Hong Kong, Zhuhai, and Tianjin, the company is a leader in the integration of traditional medicine with modern pharmaceutical technology.